Life Sciences Group Of The Year: King & Spalding

Law360, New York (February 14, 2017, 2:11 PM EST) -- King & Spalding LLP won the mid-trial dismissal of a suit claiming GlaxoSmithKline’s antidepressant Paxil causes birth defects, successfully challenged FDA guidance for R.J. Reynolds and led small biotech companies in major transactions, earning the firm a spot as one of Law360’s 2016 Groups of the Year.

The firm’s more than 300 life sciences attorneys and other professional stretch across 11 practice groups and nine offices, including in Frankfurt, Germany, and in the Middle East. They cover a broad range of life sciences matters, including U.S....
To view the full article, register now.